key: cord-0750539-co1u78cm authors: Schaefer, Joseph W.; Riley, Joshua M.; Li, Michael; Cheney‐Peters, Dianna R.; Venkataraman, Chantel M.; Li, Chris J.; Smaltz, Christa M.; Bradley, Conor G.; Lee, Crystal Y.; Fitzpatrick, Danielle M.; Ney, David B.; Zaret, Dina S.; Chalikonda, Divya M.; Mairose, Joshua D.; Chauhan, Kashyap; Szot, Margaret V.; Jones, Robert B.; Bashir‐Hamidu, Rukaiya; Mitsuhashi, Shuji; Kubey, Alan A. title: Comparing reliability of ICD‐10‐based COVID‐19 comorbidity data to manual chart review, a retrospective cross‐sectional study date: 2021-12-08 journal: J Med Virol DOI: 10.1002/jmv.27492 sha: d629bb52001af548c4cfeeeacf2d4265961aea44 doc_id: 750539 cord_uid: co1u78cm International Statistical Classification of Disease and Related Health Problems, 10th Revision codes (ICD‐10) are used to characterize cohort comorbidities. Recent literature does not demonstrate standardized extraction methods. Objective: Compare COVID‐19 cohort manual‐chart‐review and ICD‐10‐based comorbidity data; characterize the accuracy of different methods of extracting ICD‐10‐code‐based comorbidity, including the temporal accuracy with respect to critical time points such as day of admission. Design: Retrospective cross‐sectional study. Measurements: ICD‐10‐based‐data performance characteristics relative to manual‐chart‐review. Results: Discharge billing diagnoses had a sensitivity of 0.82 (95% confidence interval [CI]: 0.79–0.85; comorbidity range: 0.35–0.96). The past medical history table had a sensitivity of 0.72 (95% CI: 0.69–0.76; range: 0.44–0.87). The active problem list had a sensitivity of 0.67 (95% CI: 0.63–0.71; range: 0.47–0.71). On day of admission, the active problem list had a sensitivity of 0.58 (95% CI: 0.54–0.63; range: 0.30–0.68)and past medical history table had a sensitivity of 0.48 (95% CI: 0.43–0.53; range: 0.30–0.56). Conclusions and Relevance: ICD‐10‐based comorbidity data performance varies depending on comorbidity, data source, and time of retrieval; there are notable opportunities for improvement. Future researchers should clearly outline comorbidity data source and validate against manual‐chart‐review. Manual chart review is considered the gold standard for clinical research but requires extensive time and personnel. Using International Statistical Classification of Disease and Related Health Problems, 10th Revision codes (ICD-10) in a hospital database and/or electronic health record (EHR) is an efficient way to characterize comorbidities. Many COVID-19 studies have used ICD-10 to identify comorbidities. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Prior COVID-19 cohort studies, however, do not demonstrate standardized practice in the extraction of ICD-10-code-based comorbidity data. The purpose of this study is to compare the comorbidities identified by manual-chart-review versus ICD-10 coding in a cohort of patients hospitalized with COVID-19. The secondary aim is to characterize the accuracy of different methods of extracting ICD-10-code-based comorbidity, including the temporal accuracy with respect to critical time points such as day of admission. This retrospective cross-sectional study included all adults (age ≥ 18 years) admitted with COVID-19 to Thomas Jefferson University Hospital (TJUH) in Philadelphia from March 1st to June 6th, 2020. COVID-19 was defined as a positive SARS-CoV-2 qualitative polymerase chain reaction. We excluded patients who were transferred from another institution, pregnant, and/or incarcerated. ICD-10 codes were obtained from the Jefferson Health datamart. ICD-10 codes were sub-grouped by their source of origin in the EHR: past medical history, active problem list, and billed discharge diagnoses (i.e., summary for insurance claims). For the Jefferson Health system, the discharge billing diagnoses are entered after an encounter by nonclinical staff; the past medical history table and active problem list are populated by clinicians. The data used for analysis was transferred to an enterprise server on September 22, 2020 (108-205 days after admission). TJUH institutional review board approved this study Statistical analysis was performed using the methodology detailed by Crabb et al. 14 Our results demonstrate significant and concerning variability in ICD-10 performance depending on comorbidity, source of ICD-10-based data, and time of data retrieval. For retrospective research, discharge billing diagnoses was the most sensitive individual Compared to our study, this lower sensitivity and specificity may be due to differences between the inpatient and outpatient setting, differing institutional practices, comorbidities analyzed, and/or COVID-19 versus non-COVID-19 populations. In a comprehensive review of 51 conditions using ICD-9-based data, Wei et al. 16 found the median sensitivity was 83% with range of 3%-100%. Compared to our study, the median sensitivity is comparable to the discharge diagnoses and pooled active problem list and past medical history. This range of sensitivities demonstrates the dramatic variability in sensitivity for conditions, and we encourage institutions to verify their ICD-10-based comorbidity data. Of note, most risk calculators are used at initial presentation yet our data shows that the accuracy of the problem list on day of ad- concern. The Cleveland Clinic organizes the raw EHR data, including ICD-10 codes, into concepts from the Unified Medical Language System to inform comorbidity. 2, 18 Another study used ICD-10 codes from the problem list at the beginning of the encounter while another included used ICD-10 codes from the current and prior encounters in addition to the problem list. 1, 3 We commend these teams for clearly detailing their source as this is not always clear. To bring clarity to the literature, we encourage future publications to detail the source of the ICD-10-based data and validate its accuracy against a subset manual chart review. Our study is limited. The data is from a single-center, using a specific EHR. It is unclear if our results can be generalized. We suspect accuracy will vary based on institutional practices, including the EHR used, expectations, and/or support for documentation and billing/coding practices. This limitation, however, underscores our conclusion that other institutions/studies should manually validate their ICD-10-based-data. Further, this study is limited to a single, disease-specific cohort. Although we anticipate similar trends would emerge across populations, it is unclear if these are COVID-19-specific findings. Additionally, the comorbidities analyzed were selected based on availability in previously constructed manual-chart-review-based database. We further note that TJUH has been using its current EHR for less than 5 years which may affect discrete ICD-10-based data table reliability (i.e., based on Schultz et al., 17 we anticipate data table accuracy will improve as a patient's chart ages). The varied performance characteristics has immediate implications for COVID-19 research and resource allocation. Multivariable analyses that identify independent risk factors for COVID-19 mortality and morbidity are being used to allocate scarce resources, such as vaccines, at a public health level. Given the variability we note in ICD-10-based comorbidity identification, these studies may overand/or-under-emphasize certain comorbidities, which may affect resource allocation. Furthermore, some health systems are using EHR-based real-time COVID-19 risk scores to inform triage, treatment allocation, and more, potentially without knowing the performance characteristics of their own EHR comorbidity data. ICD-10 codes are often used to identify comorbidities for retrospective studies and clinical risk calculators. We note significant variation in performance depending on comorbidity, source of ICD-10-based data, and time of data retrieval. We note concerning features such as a CKD sensitivity of 0.3 when using past medical history on day of admission. The data suggests that COVID-19 ICD-10-based data should be reviewed and applied carefully in the clinical and public health realms, that future researchers should clearly outline source and time of comorbidity data and validate against manual chart review, and that the research community should determine consensus in standardized extraction, analysis, and reporting of ICD-10-based data. Clinical features of COVID-19 mortality: development and validation of a clinical prediction model Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19 Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease Machine learning to predict mortality and critical events in a cohort of patients with COVID-19 in New York City: model development and validation Risk factors for hospitalization, mechanical ventilation, or death among 10 131 US veterans with SARS-CoV-2 infection Hospitalization and mortality among black patients and white patients with Covid-19 Body mass index and risk for intubation or death in SARS-CoV-2 INFECtion Obesity and mortality among patients diagnosed with COVID-19: results from an integrated health care organization Association of race with mortality among patients hospitalized with coronavirus disease 2019 (COVID-19)at 92 US hospitals Characteristics associated with racial/ethnic disparities in COVID-19 outcomes in an academic health care system STROBE Statement: Available checklists. Accessed Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data Comparison of International Classification of Diseases and Related Health Problems, Tenth Revision Codes With Electronic Medical Records Among Patients With Symptoms of Coronavirus Disease Comparison of EHRbased diagnosis documentation locations to a gold standard for risk stratification in patients with multiple chronic conditions Comprehensive review of ICD-9 code accuracies to measure multimorbidity in administrative data Temporal relationship of computed and structured diagnoses in electronic health record data Extracting and utilizing electronic health data from Epic for research The research received no specific grant from any funding agency in the public, commerical, or not-for-profit sectors. The authors declare that there are no conflict of interests. The data that support the findings of this study are available from the corresponding author upon reasonable request.